Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.56 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTR1E | P28566 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9275784 | 0.80 | NPSR1 (0.53) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL380892 | 0.80 | HTT (0.52) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL10589601 | 0.80 | HTT (0.52) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL9275796 | 0.80 | NPSR1 (0.53) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL25122261 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL25122248 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL25122278 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL23007438 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL25122378 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT | |
| SCHEMBL25122224 | 0.76 | CYP2C9 (0.47) | CYP1A2RECQLHCRTR1HCRTR2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1637150-A | Activities and ph tests for the determination of the risk of obstetric and gynecologic complications | UNIBIO S R I (IT) | 2005-07-13 | — | — | CN | claimed |
| US-20050095660-A1 | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women | UNIBIO, S.R.I. (IT) | 2005-05-05 | — | — | US | claimed |
| EP-1528396-A1 | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women | UNIBIO S.R.L. (IT) | 2005-05-04 | — | — | EP | claimed |
| US-20040219617-A1 | Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples | UNIBIO S.R.L. (IT) | 2004-11-04 | — | — | US | claimed |
| EP-1360484-A1 | ENZYMATIC TEST FOR THE DETERMINATION OF THE RISK OF PATHOLOGIES RELATED TO THE PRESENCE OF SIALIDASE OR PROLIDASE ACTIVITY IN WOMEN BODY FLUID SAMPLES | UNIBIO S.R.L. (IT) | 2003-11-12 | — | — | EP | claimed |
| WO-2002065122-A1 | ENZYMATIC TEST FOR THE DETERMINATION OF THE RISK OF PATHOLOGIES RELATED TO THE PRESENCE OF SIALIDASE OR PROLIDASE ACTIVITY IN WOMEN BODY FLUID SAMPLES | UNIBIO S.R.L. (IT) | 2002-08-22 | — | — | WO | claimed |
| US-5571684-A | SOLID PHASE CONJUGATE | LITMUS CONCEPTS, INC. (US) | 1996-11-05 | — | — | US | claimed |
| EP-1360484-B1 | ENZYMATIC TEST FOR THE DETERMINATION OF THE RISK OF PATHOLOGIES RELATED TO THE PRESENCE OF SIALIDASE OR PROLIDASE ACTIVITY IN WOMEN BODY FLUID SAMPLES | UNIBIO S R L (IT) | 2008-10-29 | — | — | EP | disclosed |
| CN-1637150-A | Activities and ph tests for the determination of the risk of obstetric and gynecologic complications | UNIBIO S R I (IT) | 2005-07-13 | — | — | CN | disclosed |
| US-20050095660-A1 | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women | UNIBIO, S.R.I. (IT) | 2005-05-05 | — | — | US | disclosed |
| EP-1528396-A1 | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women | UNIBIO S.R.L. (IT) | 2005-05-04 | — | — | EP | disclosed |
| US-20040219617-A1 | Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples | UNIBIO S.R.L. (IT) | 2004-11-04 | — | — | US | disclosed |
| EP-1360484-A1 | ENZYMATIC TEST FOR THE DETERMINATION OF THE RISK OF PATHOLOGIES RELATED TO THE PRESENCE OF SIALIDASE OR PROLIDASE ACTIVITY IN WOMEN BODY FLUID SAMPLES | UNIBIO S.R.L. (IT) | 2003-11-12 | — | — | EP | disclosed |
| WO-2000065347-A9 | MULTIPLE DIAGNOSTIC DEVICE FOR A WOMAN'S HEALTH | PROCTER & GAMBLE (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-1173758-A2 | MULTIPLE DIAGNOSTIC DEVICE FOR A WOMAN'S HEALTH | The Procter & Gamble Company (US) | 2002-01-23 | — | — | EP | disclosed |
| WO-2000065347-A2 | MULTIPLE DIAGNOSTIC DEVICE FOR A WOMAN'S HEALTH | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |
| EP-0791071-B1 | ASSAY FOR PROLINE IMINOPEPTIDASE AND OTHER HYDROLYTIC ACTIVITIES | LITMUS CONCEPTS INC (US) | 1999-09-15 | — | — | EP | disclosed |
| EP-0791071-A1 | ASSAY FOR PROLINE IMINOPEPTIDASE AND OTHER HYDROLYTIC ACTIVITIES | LITMUS CONCEPTS, INC. (US) | 1997-08-27 | — | — | EP | disclosed |
| US-5571684-A | SOLID PHASE CONJUGATE | LITMUS CONCEPTS, INC. (US) | 1996-11-05 | — | — | US | disclosed |
| WO-1996015255-A2 | ASSAY FOR PROLINE IMINOPEPTIDASE AND OTHER HYDROLYTIC ACTIVITIES | LITMUS CONCEPTS, INC. (US) | 1996-05-23 | — | — | WO | disclosed |